MLCK inhibitor peptide
Discontinued ProductUnfortunately MLCK inhibitor peptide (Cat. No. 1926) has been withdrawn from sale for commercial reasons.
Competitive myosin light chain kinase (MLCK) inhibitor (Ki = 1 - 2.2 mM); derived from the calmodulin binding site of skeletal muscle MLCK. Also inhibits calmodulin.
(Modifications: Val-11 = C-terminal amide)
|Storage||Desiccate at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 1444.79. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||0.69 mL||3.46 mL||6.92 mL|
|5 mM||0.14 mL||0.69 mL||1.38 mL|
|10 mM||0.07 mL||0.35 mL||0.69 mL|
|50 mM||0.01 mL||0.07 mL||0.14 mL|
References are publications that support the products' biological activity.
Kemp et al (1987) The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence. J.Biol.Chem. 262 2542 PMID: 3818608
View Related Products by Target
View Related Products by Product Action
Keywords: MLCK inhibitor peptide, supplier, Myosin, light, chain, kinases, inhibitors, inhibits, MLCK, Myosin, Light, Chain, Kinase, Inhibitor, Calcium, Binding, Protein, Myosin, Light, Chain, Kinase, Myosin, Myosin, Light, Chain, Kinase, Tocris Bioscience
Citations for MLCK inhibitor peptide
Citations are publications that use Tocris products.
Currently there are no citations for MLCK inhibitor peptide.
MLCK inhibitor peptide Reviews
Average Rating:(Based on 0 Reviews)